ID   CPTC-ZEB2-1
AC   CVCL_C2MF
DR   DSHB; CPTC-ZEB2-1
DR   Wikidata; Q114311264
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZEB2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O60315; Human ZEB2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=29928062; DOI=10.1371/journal.pone.0199361; PMCID=PMC6013203;
RA   Navas, Tony
RA   Pfister, Thomas D.
RA   Colantonio, Simona
RA   Aziz, Amina
RA   Dieckman, Lynda
RA   Saul, Richard G.
RA   Kaczmarczyk, Jan A.
RA   Borgel, Suzanne D.
RA   Alcoser, Sergio Y.
RA   Hollingshead, Melinda G.
RA   Lee, Young H.
RA   Bottaro, Donald P.
RA   Hiltke, Tara
RA   Whiteley, Gordon R.
RA   Takebe, Naoko
RA   Kinders, Robert J.
RA   Parchment, Ralph E.
RA   Tomaszewski, Joseph E.
RA   Doroshow, James H.
RT   "Novel antibody reagents for characterization of drug- and tumor
RT   microenvironment-induced changes in epithelial-mesenchymal transition
RT   and cancer stem cells.";
RL   PLoS ONE 13:e0199361.1-e0199361.24(2018).
//